Option Care Health, Inc. OPCH Reportable Segment — Infusion services net revenue
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Option Care Health, Inc. in its filing.
Tagged under the XBRL concept us-gaap:Revenues.
The official record: Option Care Health, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Option Care Health, Inc.'s reportable segment — infusion services net revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Option Care Health, Inc.'s reportable segment — infusion services net revenue?
- Option Care Health, Inc. (OPCH) reported reportable segment — infusion services net revenue of $1.35B in Q1 2026.
- How has Option Care Health, Inc.'s reportable segment — infusion services net revenue changed year-over-year?
- Option Care Health, Inc.'s reportable segment — infusion services net revenue increased by 1.3% year-over-year, from $1.33B to $1.35B.
- What is the long-term trend for Option Care Health, Inc.'s reportable segment — infusion services net revenue?
- Over 2 years (2023 to 2025), Option Care Health, Inc.'s reportable segment — infusion services net revenue has grown at a 14.6% compound annual growth rate (CAGR), from $4.3B to $5.65B.
- What does reportable segment — infusion services net revenue mean?
- This metric represents the total revenue generated from infusion services within the reportable business segment after accounting for returns, allowances, and discounts. It serves as a primary indicator of the segment's market demand and core service delivery performance. Tracking this revenue helps investors assess the scale and growth trajectory of the company's specialized clinical service offerings.